HEPATIC STEATOSIS
Clinical trials for HEPATIC STEATOSIS explained in plain language.
Never miss a new study
Get alerted when new HEPATIC STEATOSIS trials appear
Sign up with your email to follow new studies for HEPATIC STEATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Daily shot aims to shrink dangerous liver fat
Disease control Recruiting nowThis study is testing whether a daily injection called tesamorelin can reduce fat buildup in the liver of adults with fatty liver disease. 120 participants will receive either the active drug or a placebo injection for one year, with both groups receiving lifestyle advice. The ma…
Matched conditions: HEPATIC STEATOSIS
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC
-
Cheaper, easier liver scan tested in new study
Diagnosis Recruiting nowThis study is testing a new type of ultrasound scan, called DeepUSFF, to see if it can accurately measure fat in the liver for people with fatty liver disease (MASLD). Researchers will compare the results from this new ultrasound to the results from a more expensive and less avai…
Matched conditions: HEPATIC STEATOSIS
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Diagnosis
Last updated Mar 23, 2026 15:16 UTC
-
Researchers track HIV patients to unlock secrets of liver disease progression
Knowledge-focused Recruiting nowThis study aims to create better prediction tools for liver disease in people living with HIV. Researchers will follow 320 HIV-positive participants for 5 years to understand how fatty liver disease and liver scarring develop and progress. The goal is to build models that can ide…
Matched conditions: HEPATIC STEATOSIS
Sponsor: Shanghai Public Health Clinical Center • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC